MCEDC Interview: Jeff Galvin, CEO & Founder of American Gene Technologies
In the latest of the ‘Built for Bio‘ interview series, MCEDC CEO, David Petr, discovers how Jeff is using the availability of raw talent and novel technology unique to Montgomery County, MD to develop potential cures for HIV and cancers using cell and gene therapy.
Jeff’s passion for his company, his people and the region is a hallmark of his leadership. His enthusiasm for the possibilities that cell and gene therapy technologies are enabling for patients is what fuels that passion.
“This is more important than any revolution in technology that has come before.”Jeff Galvin, CEO, American Gene Technologies
Latest posts by Chris Frew (see all)
- Global Healthcare Giant JNJ Tapped for Next Phase of DC’s Redevelopment Plans - October 15, 2019
- Jeff Caskey Joins Workforce Genetics as Life Science Talent Consultant - October 14, 2019
- Cerecor Announces $43 Million Deal with AYTU BioScience to Sell Pediatric Portfolio and Advance Towards NDA - October 14, 2019